Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
Demant operates in the medical technology sector. The company specializes in the development of hearing aids and hearing loops. The company operates on a global level where the products are sold under various brands. The products are available through the company's distributors and sales channels. In addition to its main business, the company conducts research in diagnostics for measuring hearing quality. The company was originally founded in 1904 and has its headquarters in Smörum.
An unchanged operating profit guidance with a midpoint of BDKK 4.85 vs. the expected BDKK 4.94 points toward a slightly weaker opening, as nothing new lifts the estimates following the 27% share price increase. The market grew by 7% in Q3, which keeps the upper end of the guidance within reach.
Read the full research report here:
Udsigt til en negativ åbning i Europa fra morgenstunden efter nyt udsalg i chip- og AI-aktier i Asien. Fokus på Nordea (Q3-regnskab) og NKT (Berenberg opgraderer). Gæst i studiet her til morgen er Anders Bæk, forfatter til AI Epoken, der bl.a. vil tale om en mulig AI-boble og skiftet fra chatbots til AI-agenter.
Udsigt til en positiv åbning i Europa fra morgenstunden efter faldende oliepriser. Gæst i studiet her til morgen er CEO Kasper Gjedsted fra GreenMobility, der bl.a. vil tale om selskabets Q3-trading statement og selvkørende biler.
Udsigt til en svag negativ åbning i Europa fra morgenstunden efter fald i Asien. Fokus på Bavarian Nordic (opjustering) og Zealand Pharma (fase 2-data i fedme). Gæst i studiet her til morgen er cheføkonom Søren Kristensen fra AL Sydbank, der bl.a. vil tale om rentestigningerne.
Igen udsigt til en afventende åbning i Europa. Stort fokus på Vestas og Demant der begge opjusterer. Gæst i studiet her til morgen er CEO Lars Højgård Hansen fra INVISIO.
The share is expected to open higher: Demant raised its 2026 operating profit midpoint to DKK 4,600M, exceeding analysts' expectations of DKK 4,539M. The catch: sales grew 18% before currency effects, yet the operating margin only reached 16.5% vs. 16.4% last year.
